Venture Life Group (VLG.L) Stock Price

Venture Life Group Price

LSE·CLOSED
0.68GBP-0.0015 (-0.23 %)
Market closed

Over the last 14 years Venture Life Group grew revenue by 49.0% annually, reaching 26.59 M GBP. Earnings per share have grown at 14.1% per year over the last 5 years. For Venture Life Group, the net margin of -1.2% is down versus 7.9% a few years ago. At today's price the dividend yield works out to roughly 0.06%. The payout ratio is around 11% of earnings. The consensus 12-month price target for Venture Life Group is 102.00 GBP, about 14,900.0% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 27% above its 52-week low.

Venture Life Group stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Venture Life Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Venture Life Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Venture Life Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Venture Life Group Stock Price History
DateVenture Life Group Price
8/13/20260.68 GBP
8/12/20260.68 GBP
8/11/20260.69 GBP
8/10/20260.69 GBP
8/7/20260.69 GBP
8/6/20260.69 GBP
8/5/20260.70 GBP
8/4/20260.70 GBP
7/31/20260.70 GBP
7/30/20260.69 GBP
7/29/20260.70 GBP
7/28/20260.70 GBP
7/27/20260.70 GBP
7/24/20260.70 GBP
7/23/20260.71 GBP
7/22/20260.70 GBP
7/21/20260.70 GBP
7/20/20260.70 GBP
7/17/20260.69 GBP
7/16/20260.70 GBP
7/15/20260.69 GBP
7/14/20260.69 GBP
7/13/20260.67 GBP
7/10/20260.67 GBP
7/9/20260.67 GBP
7/8/20260.66 GBP
7/7/20260.66 GBP
7/6/20260.66 GBP
7/3/20260.67 GBP
7/2/20260.66 GBP
7/1/20260.66 GBP
6/30/20260.66 GBP
6/29/20260.67 GBP
6/26/20260.67 GBP
6/25/20260.66 GBP
6/24/20260.67 GBP
6/23/20260.67 GBP
6/22/20260.67 GBP
6/19/20260.66 GBP
6/18/20260.67 GBP
6/17/20260.67 GBP
6/16/20260.67 GBP
6/15/20260.67 GBP
6/12/20260.67 GBP
6/11/20260.67 GBP
6/10/20260.67 GBP
6/9/20260.67 GBP
6/8/20260.65 GBP
6/5/20260.66 GBP
6/4/20260.66 GBP
6/3/20260.65 GBP
6/2/20260.57 GBP
6/1/20260.57 GBP
5/29/20260.57 GBP
5/28/20260.57 GBP
5/27/20260.57 GBP
5/26/20260.57 GBP
5/22/20260.57 GBP
5/21/20260.57 GBP
5/20/20260.57 GBP
5/19/20260.57 GBP
5/18/20260.57 GBP
5/15/20260.57 GBP
5/14/20260.57 GBP
5/13/20260.57 GBP
5/12/20260.57 GBP
5/11/20260.56 GBP
5/8/20260.55 GBP
5/7/20260.56 GBP
5/6/20260.57 GBP
5/5/20260.57 GBP
5/1/20260.57 GBP
4/30/20260.58 GBP
4/29/20260.58 GBP
4/28/20260.59 GBP
4/27/20260.62 GBP
4/24/20260.63 GBP
4/23/20260.64 GBP
4/22/20260.63 GBP
4/21/20260.65 GBP
4/20/20260.66 GBP
4/17/20260.66 GBP
4/16/20260.67 GBP
4/15/20260.67 GBP
4/14/20260.66 GBP
4/13/20260.66 GBP
4/10/20260.66 GBP
4/9/20260.65 GBP
4/8/20260.65 GBP
4/7/20260.64 GBP
4/2/20260.64 GBP
4/1/20260.65 GBP
3/31/20260.66 GBP
3/30/20260.68 GBP
3/27/20260.68 GBP
3/26/20260.68 GBP
3/25/20260.68 GBP
3/24/20260.68 GBP
3/23/20260.68 GBP
3/20/20260.68 GBP
3/19/20260.69 GBP
3/18/20260.69 GBP
3/17/20260.69 GBP
3/16/20260.69 GBP
3/13/20260.69 GBP
3/12/20260.69 GBP
3/11/20260.69 GBP
3/10/20260.68 GBP
3/9/20260.68 GBP
3/6/20260.67 GBP
2/20/20260.69 GBP
2/18/20260.70 GBP
2/17/20260.70 GBP
2/16/20260.69 GBP
2/13/20260.71 GBP
2/12/20260.71 GBP
2/11/20260.71 GBP
2/10/20260.70 GBP
2/9/20260.71 GBP
2/6/20260.70 GBP
2/5/20260.68 GBP
2/4/20260.68 GBP
2/3/20260.68 GBP
2/2/20260.68 GBP
1/30/20260.67 GBP
1/29/20260.68 GBP
1/28/20260.68 GBP
1/27/20260.68 GBP
1/26/20260.67 GBP
1/23/20260.66 GBP
1/22/20260.66 GBP
1/21/20260.66 GBP
1/20/20260.65 GBP
1/19/20260.64 GBP
1/16/20260.68 GBP
1/15/20260.68 GBP
1/14/20260.67 GBP
1/13/20260.67 GBP
1/12/20260.67 GBP
1/9/20260.67 GBP
1/8/20260.66 GBP
1/7/20260.67 GBP
1/6/20260.67 GBP
1/5/20260.67 GBP
1/2/20260.66 GBP
12/31/20250.66 GBP
12/30/20250.66 GBP
12/29/20250.66 GBP
12/24/20250.66 GBP
12/23/20250.66 GBP
12/22/20250.66 GBP
12/19/20250.66 GBP
12/18/20250.66 GBP
12/17/20250.65 GBP
12/16/20250.64 GBP
12/15/20250.62 GBP
12/12/20250.62 GBP
12/11/20250.62 GBP
12/10/20250.62 GBP
12/9/20250.62 GBP
12/8/20250.61 GBP
12/5/20250.62 GBP
12/4/20250.62 GBP
12/3/20250.61 GBP
12/2/20250.61 GBP
12/1/20250.61 GBP
11/28/20250.61 GBP
11/27/20250.61 GBP
11/26/20250.59 GBP
11/25/20250.59 GBP
11/24/20250.59 GBP
11/21/20250.59 GBP
11/20/20250.59 GBP
11/19/20250.58 GBP
11/18/20250.58 GBP
11/17/20250.61 GBP
11/14/20250.59 GBP
11/13/20250.59 GBP
11/12/20250.58 GBP
11/11/20250.55 GBP
11/10/20250.54 GBP
11/7/20250.54 GBP
11/6/20250.54 GBP
11/5/20250.54 GBP
11/4/20250.54 GBP
11/3/20250.54 GBP
10/31/20250.56 GBP
10/30/20250.55 GBP
10/29/20250.54 GBP
10/28/20250.54 GBP
10/27/20250.55 GBP
10/24/20250.56 GBP
10/23/20250.55 GBP
10/22/20250.55 GBP
10/21/20250.56 GBP
10/20/20250.56 GBP
10/17/20250.56 GBP
10/16/20250.57 GBP
10/15/20250.55 GBP
10/14/20250.55 GBP
10/13/20250.55 GBP
10/10/20250.56 GBP
10/9/20250.54 GBP
10/8/20250.54 GBP
10/7/20250.54 GBP
10/6/20250.54 GBP
10/3/20250.56 GBP
10/2/20250.56 GBP
10/1/20250.56 GBP
9/30/20250.56 GBP
9/29/20250.55 GBP
9/26/20250.55 GBP
9/25/20250.56 GBP
9/24/20250.55 GBP
9/23/20250.56 GBP
9/22/20250.56 GBP
9/19/20250.57 GBP
9/18/20250.57 GBP
9/17/20250.56 GBP
9/16/20250.56 GBP
9/15/20250.57 GBP
9/12/20250.58 GBP
9/11/20250.59 GBP
9/10/20250.60 GBP
9/9/20250.60 GBP
9/8/20250.60 GBP
9/5/20250.60 GBP
9/4/20250.60 GBP
9/3/20250.60 GBP
9/2/20250.60 GBP
9/1/20250.62 GBP
8/29/20250.59 GBP
8/28/20250.57 GBP
8/27/20250.57 GBP
8/26/20250.57 GBP
8/22/20250.58 GBP
8/21/20250.58 GBP
8/20/20250.59 GBP
8/19/20250.59 GBP
8/18/20250.58 GBP
Access this data via the Eulerpool API

Venture Life Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
30.08 M GBP
4.13 M GBP
2.37 M GBP
Jan 1, 2021
32.76 M GBP
2.57 M GBP
2.40 M GBP
Jan 1, 2022
43.98 M GBP
3.33 M GBP
520,000.00 GBP
Jan 1, 2023
22.37 M GBP
2.04 M GBP
921,000.00 GBP
Jan 1, 2024
26.59 M GBP
3.14 M GBP
-314,000.00 GBP
Jan 1, 2025 (e)
51.91 M GBP
1.96 M GBP
4.96 M GBP
Jan 1, 2026 (e)
43.88 M GBP
4.74 M GBP
6.79 M GBP
Jan 1, 2027 (e)
47.90 M GBP
6.18 M GBP
8.61 M GBP

Venture Life Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 15, 2026, 5:00 AM
 
REVENUEM GBP
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM GBP
EBITM GBP
EBIT MARGIN%
NET INCOMEM GBP
NET INCOME GROWTH%
DIV.GBP
SHARESM
20122013201420152016201720182019202020212022202320242025e2026e2027e
7.009.0014.0016.0018.0020.0030.0032.0043.0022.0026.0051.0043.0047.00
28.5755.5614.2912.5011.1150.006.6734.38-48.8418.1896.15-15.699.30
28.5733.3335.7137.5038.8940.0040.0037.5039.5340.9146.1546.1546.1546.15
12.0012.002.003.005.006.007.008.0012.0012.0017.009.0012.0023.5419.8521.69
-1.00-1.001.001.004.002.003.002.003.001.004.006.00
-14.29-11.115.565.0013.336.256.989.0911.541.969.3012.77
-1.00-1.00-1.00-1.002.002.004.006.008.00
50.0033.33
24.2624.2626.1334.4536.4636.8962.5889.3893.42133.82133.39126.50126.72126.72126.72126.72
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Venture Life Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Venture Life Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Venture Life Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Venture Life Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Venture Life Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Venture Life Group stock margins

The Venture Life Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Venture Life Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Venture Life Group.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
42.72 %
13.72 %
7.87 %
Jan 1, 2021
39.55 %
7.84 %
7.33 %
Jan 1, 2022
40.17 %
7.56 %
1.18 %
Jan 1, 2023
41.55 %
9.12 %
4.12 %
Jan 1, 2024
45.82 %
11.79 %
-1.18 %
Jan 1, 2025 (e)
45.82 %
3.77 %
9.55 %
Jan 1, 2026 (e)
45.82 %
10.80 %
15.47 %
Jan 1, 2027 (e)
45.82 %
12.90 %
17.99 %

Venture Life Group Stock Revenue, EBIT, Earnings per Share

The Venture Life Group earnings per share therefore indicates how much revenue Venture Life Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.32 GBP
0.04 GBP
0.03 GBP
Jan 1, 2021
0.24 GBP
0.02 GBP
0.02 GBP
Jan 1, 2022
0.33 GBP
0.02 GBP
0.00 GBP
Jan 1, 2023
0.18 GBP
0.02 GBP
0.01 GBP
Jan 1, 2024
0.21 GBP
0.02 GBP
-0.00 GBP
Jan 1, 2025 (e)
0.41 GBP
0.02 GBP
0.04 GBP
Jan 1, 2026 (e)
0.35 GBP
0.04 GBP
0.05 GBP
Jan 1, 2027 (e)
0.38 GBP
0.05 GBP
0.07 GBP

Venture Life Group business model & stock analysis

The Venture Life Group PLC was founded in 2010 and is based in the United Kingdom. This company operates in the health and wellness industry and specializes in the development, manufacturing, and marketing of lifestyle products. Venture Life's business model is based on developing products that can simplify and enhance people's everyday lives. This includes not only dietary supplements and medical devices, but also beauty and skincare products, as well as insect repellents. The company is divided into various divisions, each focusing on different products. Venture Life Europe, the company's main pillar, focuses on dietary supplements and medical devices. This includes products such as sterile wound dressings and blood glucose monitors. The Southern Europe division specializes in dermatology products and insect repellents. In North America, Venture Life operates through its subsidiary Biokosmes, specializing in beauty and skincare products. Other divisions of the company, such as Nordic Life Science and Farma Mediterranea, produce dietary supplements and collagen products. The company offers a wide range of products, including products like Just for Tummies, which are designed to support the immune and digestive systems, and Dentyl pH, which promotes lasting oral hygiene. Another product range from Venture Life is UltraDEX, which focuses on tongue and dental health, as well as oral care. Another product is the insect repellent Mosi-Guard, which is offered in various forms such as lotion, spray, and roll-on. In recent years, Venture Life has also made acquisitions to strengthen its presence in specific markets and expand its product range. These acquisitions include UltraDex, a company focused on oral hygiene, and PharmaSource, a supplier of pharmaceutical raw materials. Under the leadership of Jerry Randall, Venture Life has developed an experienced management team and a strong strategy for expanding into new markets and product categories. The company has an extensive network of customers and distribution partners and has built its reputation on high-quality products and excellent customer service. Overall, Venture Life Group PLC is an innovative company with a wide range of products that focuses on improving its customers' daily lives. With a strong strategy and experienced leadership team, the company has established a good position in the industry and looks optimistically towards the future.

Venture Life Group SWOT Analysis

Strengths

  • Strong brand reputation in the healthcare industry.
  • Diversified product portfolio offering a range of healthcare solutions.
  • Well-established distribution network and presence in multiple countries.

Weaknesses

  • Relatively small market share compared to larger competitors.
  • Limited financial resources for extensive research and development.
  • Vulnerability to changes in healthcare regulations and policies.

Opportunities

  • Growing demand for healthcare products and services globally.
  • Expansion into emerging markets with untapped potential.
  • Strategic partnerships and collaborations for product innovation.

Threats

  • Intense competition from larger and more established companies.
  • Economic downturns affecting consumer purchasing power.
  • Regulatory challenges and compliance requirements.

Venture Life Group Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Venture Life Group historical P/E ratio, EBIT multiple, and P/S ratio

Venture Life Group annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Venture Life Group shares outstanding

The number of shares of Venture Life Group was 126.72 M in 2025. This indicates how many shares Venture Life Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
93.42 M Stocks
Jan 1, 2021
133.82 M Stocks
Jan 1, 2022
133.39 M Stocks
Jan 1, 2023
126.50 M Stocks
Jan 1, 2024
126.72 M Stocks
Jan 1, 2025 (e)
126.72 M Stocks
Jan 1, 2026 (e)
126.72 M Stocks
Jan 1, 2027 (e)
126.72 M Stocks

Venture Life Group Dividend History

5 years of dividend payments

YearAnnual DividendYoY ChangePayments
20180.00GBP 0.0%
20170.00GBP 0.0%
20160.00GBP 10.0%
20150.00GBP 0.0%
20140.00GBP

Venture Life Group dividend history and estimates

In 2025, Venture Life Group paid a dividend amounting to 0.00 GBP. Dividend means that Venture Life Group distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2014
0.00 GBP
0.00 GBP
Jan 1, 2015 (e)
0.00 GBP
0.00 GBP
Jan 1, 2016
0.00 GBP
0.00 GBP
Jan 1, 2017 (e)
0.00 GBP
0.00 GBP
Jan 1, 2018 (e)
0.00 GBP
0.00 GBP
Jan 1, 2025 (e)
0.00 GBP
0.00 GBP
Jan 1, 2026 (e)
0.00 GBP
0.00 GBP
Jan 1, 2027 (e)
0.00 GBP
0.00 GBP

Venture Life Group dividend payout ratio

In 2025, Venture Life Group had a payout ratio of 2.04%. The payout ratio indicates the percentage of the company's profits that Venture Life Group distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
10.51 %
Jan 1, 2021
10.51 %
Jan 1, 2022
10.51 %
Jan 1, 2023
10.51 %
Jan 1, 2024
10.51 %
Jan 1, 2025 (e)
2.04 %
Jan 1, 2026 (e)
1.49 %
Jan 1, 2027 (e)
1.18 %

Current Venture Life Group forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
88.89 % (8)
Hold
11.11 % (1)
Sell
0.00 % (0)
12M Price Target
1.02
Last Price
0.68
Currency
GBP
12M Return Potential
50.00 %
LTM Return
0 %

Venture Life Group shareholder structure

% Name
27.93830%
Slater Investments Ltd.
Slater Investments Ltd.
9.14362%
Business Growth Fund Limited
Business Growth Fund Limited
8.14903%
River Global Investors LLP
River Global Investors LLP
7.59027%
TrinityBridge
TrinityBridge
6.93950%
Hargreaves Lansdown Asset Management Limited
Hargreaves Lansdown Asset Management Limited
6.64763%
Stonehage Fleming Investment Management Limited
Stonehage Fleming Investment Management Limited

Venture Life Group Executives and Management Board

6 members · avg. age 60 · 0 % women

JR

Mr. Jerry Randall

Chief Executive Officer, Executive Director · since 2010

392,985.00 GBP

Management

GB

Mr. Gianluca Braguti

Executive Director, Chief Manufacturing Officer · since 2014

289,226.00 GBP
DW

Mr. Daniel Wells

Chief Financial Officer, Executive Director · since 2021

244,728.00 GBP

Board of Directors

PM

Mr. Paul Mcgreevy

Independent Non-Executive Chairman of the Board

83,506.00 GBP
MA

Mr. Mark Adams (60)

Senior Independent Non-Executive Director

40,148.00 GBP
CD

Mr. Carl Dempsey

Independent Non-Executive Director

37,513.00 GBP

Venture Life Group Supply Chain

Venture Life Group Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
14 companies
#NameTrend
1
Ocado Group
Customer·Food & Staples Retailing·GB
0.16
0.67
0.46
0
0.68
0.82
2
Hikma Pharmaceuticals
Customer·Pharmaceuticals·GB
-0.46
0.52
0.53
-0.13
0.78
0.76
3
Hargreaves Lansdown
Supplier·Customer·Capital Markets·GB
0.72
0.64
0.57
0.25
0.74
0.74
#NameTrend
1
Tesco
Customer·Food & Staples Retailing·GB
0.64
0.49
0.54
0.40
-0.86
-0.90
2
River & Mercantile Group
Supplier·Customer·Capital Markets·GB
-0.42
0.08
0.35
-0.03
-0.78
-0.85
3
Alliance Pharma
Customer·Pharmaceuticals·GB
-0.18
0.55
0.25
0.01
-0.44
-0.72
4
J Sainsbury
Customer·Food & Staples Retailing·GB
0.51
-0.20
0.44
0.37
0.39
-0.48
5
Walgreens Boots Alliance
Customer·Food & Staples Retailing·US
-0.11
0.50
0.65
0.56
0.39
-0.28

Frequently asked questions about Venture Life Group

The business model of Venture Life Group PLC focuses on the development, manufacturing, and commercialization of innovative products in the healthcare sector. By leveraging their expertise and strategic partnerships, Venture Life Group PLC creates and sells a range of medical devices, cosmetics, and nutritional products. They aim to improve the quality of life for their customers by providing high-quality, scientifically validated solutions. Through continuous research and development, Venture Life Group PLC stays at the forefront of the industry, ensuring their products meet the evolving needs of healthcare professionals and end-users.

Venture Life Group PLC is primarily active in the healthcare and consumer wellness industries. The company focuses on developing, manufacturing, and marketing a wide range of innovative products in these sectors. With a strong emphasis on quality and customer satisfaction, Venture Life Group PLC aims to meet the diverse needs of individuals across various healthcare segments. This dedication has positioned the company as a leading player in the healthcare industry, providing effective solutions and improving the well-being of consumers worldwide.

The main competitors of Venture Life Group PLC in the market are companies like Johnson & Johnson, Procter & Gamble, and Unilever.

Venture Life Group PLC is a UK-based international consumer healthcare company. Founded in 2010, the company focuses on the development, manufacturing, and commercialization of innovative products for the self-care market. Venture Life Group PLC offers a wide range of products, including medical devices, oral care products, and dermatological solutions. With a strong track record of delivering high-quality products, the company has expanded its presence across Europe and other international markets. Venture Life Group PLC's commitment to innovation and its strategic partnerships with leading healthcare companies have contributed to its success in providing effective and accessible healthcare solutions globally.

Venture Life Group PLC has achieved several significant milestones throughout its journey. The company successfully expanded its product portfolio by launching innovative brands and entering into strategic partnerships. They have also demonstrated impressive market growth and secured distribution agreements in multiple regions. Moreover, Venture Life Group PLC has consistently maintained a strong financial position, generating substantial revenue and delivering impressive shareholder returns. These achievements highlight the company's successful track record and commitment to driving growth and excellence in the healthcare industry.

Venture Life Group PLC is primarily present in multiple countries and regions. The company has an extensive international presence with its operations spanning across Europe, Asia, and the Middle East. Some key countries where Venture Life Group PLC operates include the United Kingdom, Italy, Spain, Portugal, France, Germany, the Netherlands, China, and the United Arab Emirates. With its focus on global expansion, Venture Life Group PLC continues to establish a strong presence in these regions, combining its expertise in the healthcare and consumer wellness sectors to provide innovative solutions to customers worldwide.

Venture Life Group PLC is a company that values innovation, excellence, and integrity in all aspects of its operations. Their corporate philosophy is centered around delivering high-quality healthcare and personal care products to customers worldwide. With a focus on research and development, Venture Life Group PLC aims to enhance people's lives through their innovative product offerings. Their commitment to ethical practices and sustainable growth makes them a trusted choice for customers seeking reliable healthcare solutions. Venture Life Group PLC's dedication to customer satisfaction and continuous improvement sets them apart in the industry, making them a leading player in the global healthcare market.

Analysts currently set an average price target of 102.00 GBP for the Venture Life Group stock (median: 102.00 GBP), implying +50.0 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Venture Life Group stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Venture Life Group to generate revenue of 43.88 M GBP and earnings per share of 0.05 GBP.

Converted at the current exchange rate, the Venture Life Group share trades at 0.80 EUR (0.68 GBP).

The Venture Life Group share (VLG.L) is listed on 3 stock exchanges, including: Frankfurt (17V.F), London (VLG.L), London (VLG.L).

The Venture Life Group PLC is a global consumer goods company in the health and wellness sector, focusing on the development and marketing of products for the over-the-counter (OTC) and professional markets. The company operates in four business segments: the dermatology category, the oral health category, the animal health category, and the lifestyle products category. The dermatology category develops and distributes products for the treatment of skin problems such as acne, eczema, psoriasis, and skin infections. Some of the brand-name products include DermaSilk, UltraDEX, and New Skin. In the oral health category, Venture Life produces mouthwashes and toothpastes tailored to specific needs. They have several brands in their portfolio, including UltraDEX, NeuBrite, and Dentyl. The animal health category includes a wide range of health and wellness products for pets. The product range includes shampoos, lotions, wound creams, vitamin supplements, and flea and tick treatments. The products are available under the brand names Proderm, Vetruus, and UltraBeau. Lifestyle products are also offered, including Venetiaurum, a dietary supplement for skin, hair, and nails; Kultura, a probiotic for the gut; and Lubatti, a luxurious beauty salon. Venture Life Group's business model is based on product development and distribution, with a focus on innovation and quality. The company utilizes an efficient and agile business model that accelerates the development process from idea to market launch and reduces administrative costs. Venture Life works closely with research and development departments as well as external partner companies to leverage innovative technologies, active ingredients, and platforms for the development of new products. The company also places great importance on its international distribution channels and works with leading retailers worldwide to promote the distribution of its products. Online sales platforms also play a major role in the business model, including the company's own website, which is available to customers in the EU, North America, and Asia. Venture Life Group PLC is a rapidly growing company with strong brands and a forward-thinking business model. It is a leading provider of health and wellness products for consumers and the professional market.

The expected revenue of Venture Life Group is 43.88 M GBP. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Venture Life Group is 6.79 M GBP. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Venture Life Group is currently 12.70. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Venture Life Group stock.

The price-to-sales ratio (P/S) of Venture Life Group is currently 1.96. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Venture Life Group stock.

The Eulerpool Quality Score for Venture Life Group is 3/10.

The ISIN of Venture Life Group is GB00BFPM8908. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Venture Life Group is A110ZQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Venture Life Group is VLG.L. The ticker symbol is used to trade Venture Life Group shares on the stock exchange.

Over the past 12 months, Venture Life Group paid a dividend of 0.00 GBP . This corresponds to a dividend yield of about 0.06 %. For the coming 12 months, Venture Life Group is expected to pay a dividend of 0.00 GBP.

The current dividend yield of Venture Life Group is 0.06 %.

Venture Life Group pays a dividend, distributed in the months of , , , .

Venture Life Group paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.00 GBP are expected. This corresponds to a dividend yield of 0.12 %.

Venture Life Group is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of Venture Life Group from amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Venture Life Group are distributed in GBP.